Location History:
- Newark, DE (US) (2013 - 2017)
- Newark, NJ (US) (2019)
Company Filing History:
Years Active: 2013-2019
Title: Innovations of Jinglong Chen in Inflammatory Response Modulation
Introduction
Jinglong Chen is a notable inventor based in Newark, DE (US), recognized for his contributions to the field of pharmaceutical and cosmetic innovations. He holds a total of four patents, showcasing his commitment to advancing medical science and improving health outcomes.
Latest Patents
Among his latest patents is a significant invention related to isoprenyl compounds and methods thereof. This invention provides novel isoprenyl compounds capable of effectively modulating inflammatory responses. The anti-inflammatory compounds developed through this invention are useful in treating or preventing diseases or conditions associated with inflammation. Additionally, proinflammatory compounds are designed to address diseases or conditions associated with the suppression of inflammatory responses. The invention also outlines methods useful in the treatment or prevention of these inflammatory-related diseases.
Career Highlights
Jinglong Chen is currently associated with Signum Biosciences, Inc., where he continues to innovate and contribute to the field of biochemistry and pharmacology. His work focuses on developing compounds that can significantly impact health and wellness.
Collaborations
He collaborates with notable colleagues, including Jeffry B Stock and Maxwell Stock, who contribute to his research and development efforts.
Conclusion
Jinglong Chen's work in the development of isoprenyl compounds represents a significant advancement in the treatment of inflammatory conditions. His innovative approach and dedication to research continue to pave the way for future breakthroughs in the pharmaceutical industry.